Michael Barbella, Managing Editor02.16.23
G Medical Innovations Holdings Ltd. has been awarded two U.S. patents for its monitoring products.
The granted patents are:
The company’s current product lines consist of its Prizma medical device (or Prizma), a clinical-grade device that can transform almost any smartphone into a medical monitoring device, enabling both healthcare providers and individuals to monitor, manage and share a wide range of vital signs and biometric indicators; its Extended Holter and Monitoring Cardiac Telemetry Patch services, utilizing a multi-channel patient-worn biosensors, with algorithms for real time analysis and transmission that captures electrocardiography (i.e. ECG) data continuously, including QT Syndrome Prolongation Detection. In addition, the company is developing a Wireless Vital Signs Monitoring System (or VSMS), which is expected to provide full, continuous, and real-time monitoring of a wide range of vital signs and biometrics. Its monitoring services include provision of Independent Diagnostic Testing Facility (i.e. IDTF) monitoring services and private monitoring services.
G Medical Innovations Holdings Ltd. is developing next-generation mHealth and telemedicine solutions and monitoring service platforms. The company’s solutions and services can help consumers, patients, and providers better monitor, manage, and improve clinical and personal health outcomes, especially for those who suffer from cardiovascular disease (or CVD), pulmonary disease, and diabetes.
The granted patents are:
- Method, Device, and System for Non-Invasively Monitoring Physiological Parameters - This patent integrates a sensing mechanism that allows the monitoring system to analyze the sensing condition (pressure, ambient temperature, light, conductivity, etc.) prior to performing and during continuous monitoring of the body's physiological signals. This allows higher and more accurate sensing that results in reducing false positive reading including false alarms.
- Jacket for Medical Module - This patent harnesses the traditional smartphone flip case concept and converts it to a medical case, allowing consumers and patients to carry their smartphones and monitoring device together. The conversion ensures the ability of monitoring vital signs and other parameters anywhere at any time.
The company’s current product lines consist of its Prizma medical device (or Prizma), a clinical-grade device that can transform almost any smartphone into a medical monitoring device, enabling both healthcare providers and individuals to monitor, manage and share a wide range of vital signs and biometric indicators; its Extended Holter and Monitoring Cardiac Telemetry Patch services, utilizing a multi-channel patient-worn biosensors, with algorithms for real time analysis and transmission that captures electrocardiography (i.e. ECG) data continuously, including QT Syndrome Prolongation Detection. In addition, the company is developing a Wireless Vital Signs Monitoring System (or VSMS), which is expected to provide full, continuous, and real-time monitoring of a wide range of vital signs and biometrics. Its monitoring services include provision of Independent Diagnostic Testing Facility (i.e. IDTF) monitoring services and private monitoring services.
G Medical Innovations Holdings Ltd. is developing next-generation mHealth and telemedicine solutions and monitoring service platforms. The company’s solutions and services can help consumers, patients, and providers better monitor, manage, and improve clinical and personal health outcomes, especially for those who suffer from cardiovascular disease (or CVD), pulmonary disease, and diabetes.